Hepatitis B Virus: Structure, Replication, Pathogenesis, Variants, Epidemiology, Prevention and Diagnosis

 

Introduction

Hepatitis means inflammation of the liver. Viral hepatitis is one of the most important infectious diseases affecting humans worldwide. Several different viruses can cause hepatitis, but the major human hepatitis viruses are Hepatitis A virus (HAV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), Hepatitis D virus (HDV), Hepatitis E virus (HEV), and Hepatitis G virus (HGV). These viruses differ in their genetic material, structure, routes of transmission, incubation period, clinical manifestations, and ability to cause chronic infection.

The liver performs many essential functions, including metabolism of nutrients, detoxification of harmful substances, synthesis of proteins, and production of bile. When hepatitis viruses infect liver cells, they can cause inflammation and damage to the liver. Some infections are short-lasting and resolve completely, whereas others may become chronic and lead to cirrhosis, liver failure, or hepatocellular carcinoma.

 

1. General Properties of Hepatitis Viruses

The major hepatitis viruses are not members of one single viral family. They belong to different virus families and therefore have different structural and biological characteristics.

 

Virus	Full name	Genetic material	Envelope	Main transmission	Chronic infection
HAV	Hepatitis A virus	RNA	No	Fecal–oral	No
HBV	Hepatitis B virus	Partially double-stranded DNA	Yes	Blood, sexual, perinatal	Yes
HCV	Hepatitis C virus	RNA	Yes	Mainly blood-borne	Yes
HDV	Hepatitis D virus	RNA	Yes; uses HBV envelope	Blood, sexual, perinatal	Yes, mainly with HBV
HEV	Hepatitis E virus	RNA	Generally non-enveloped in transmission	Fecal–oral	Usually no
HGV/GBV-C	Hepatitis G virus	RNA	Yes	Mainly blood-borne	Can persist

 

Important characteristics

HAV

• HAV is a small, non-enveloped, positive-sense single-stranded RNA virus.
• It belongs to the Picornaviridae family.
• It is relatively resistant to environmental conditions.
• It mainly infects the liver.
• Infection generally produces acute hepatitis.
• It does not normally cause chronic hepatitis.

HBV

• HBV is an enveloped DNA virus.
• It belongs to the Hepadnaviridae family.
• Its genome is partially double-stranded circular DNA.
• HBV contains a unique viral polymerase with reverse-transcriptase activity.
• It has several important antigens, including HBsAg, HBcAg, and HBeAg.
• It can cause both acute and chronic infection.

HCV

• HCV is an enveloped, positive-sense single-stranded RNA virus.
• It belongs to the Flaviviridae family.
• HCV has substantial genetic variation.
• This genetic variability helps the virus escape immune responses.
• Chronic infection is common.
• Long-term infection can result in cirrhosis and liver cancer.

HDV

• HDV is a small RNA virus that is defective because it requires HBV for its life cycle.
• It cannot produce a complete infectious particle independently.
• It uses the HBV surface antigen (HBsAg) to form its envelope.
• Infection can occur as co-infection with HBV or as superinfection in a person who already has HBV.

HEV

• HEV is a small, positive-sense single-stranded RNA virus.
• It belongs to the Hepeviridae family.
• It is mainly transmitted by the fecal–oral route.
• HEV commonly causes acute hepatitis.
• Severe disease can occur in some pregnant women and other vulnerable individuals.
• Chronic infection can occur particularly in some immunocompromised patients.

HGV

• HGV, now commonly called GB virus C (GBV-C), is an enveloped RNA virus related to HCV.
• It is mainly transmitted through blood and other exposures involving infected blood.
• Although it was originally investigated as a cause of hepatitis, its role as a significant cause of human hepatitis remains uncertain.
• Persistent infection can occur.

 

2. General Pathogenesis of Viral Hepatitis

The pathogenesis of viral hepatitis involves several steps.

Step 1: Entry into the body

The virus enters through an appropriate route depending on the virus. HAV and HEV commonly enter through contaminated food or water, whereas HBV, HCV, and HDV commonly enter through infected blood or other body fluids.

Step 2: Infection of liver cells

After entering the body, the virus reaches the liver and infects hepatocytes, the major functional cells of the liver.

Step 3: Viral replication

The virus uses the host cell machinery to produce new viral components and viral particles.

Step 4: Immune response

Much of the liver injury in viral hepatitis results from the body's immune response against infected hepatocytes, rather than simply from direct destruction by the virus.

Step 5: Liver inflammation

The immune response causes inflammation and damage to liver tissue. This may produce symptoms such as:

• Fever
• Fatigue
• Loss of appetite
• Nausea
• Abdominal discomfort
• Dark urine
• Jaundice

Step 6: Resolution or chronic infection

Depending on the virus and the host's immune response, infection may:

• Resolve completely
• Produce prolonged or chronic infection
• Cause progressive liver damage
• Lead to cirrhosis or liver cancer

 

3. Hepatitis A Virus (HAV)

General Properties

HAV is a non-enveloped, positive-sense single-stranded RNA virus belonging to the Picornaviridae family.

It primarily infects hepatocytes and causes acute hepatitis. Unlike HBV and HCV, HAV does not normally produce chronic infection.

Transmission

HAV is mainly transmitted by the fecal–oral route.

Major routes include:

• Contaminated drinking water
• Contaminated food
• Poor sanitation
• Poor personal hygiene
• Close contact with an infected person
• Consumption of contaminated raw or inadequately prepared food

Pathogenesis

After ingestion, HAV passes through the gastrointestinal tract and reaches the liver. It replicates in hepatocytes and is released into bile and then into the intestine.

The immune response against infected liver cells causes inflammation and liver injury.

Diseases caused by HAV

HAV mainly causes:

1. Acute hepatitis A

Symptoms may include:

• Fever
• Fatigue
• Loss of appetite
• Nausea and vomiting
• Abdominal discomfort
• Dark urine
• Pale stool
• Jaundice

Children may have mild or asymptomatic infections, while adults are more likely to develop noticeable symptoms.

2. Fulminant hepatitis

Rarely, severe acute liver failure can occur, particularly in people with underlying liver disease.

Important point

HAV does not normally cause chronic hepatitis or chronic carrier states.

 

4. Hepatitis B Virus (HBV)

General Properties

HBV is an enveloped, partially double-stranded DNA virus belonging to the Hepadnaviridae family.

Important viral components include:

• HBsAg: Hepatitis B surface antigen
• HBcAg: Hepatitis B core antigen
• HBeAg: Hepatitis B e antigen
• Viral DNA polymerase

HBV has a unique replication mechanism involving reverse transcription.

Transmission

HBV can be transmitted through infected blood and body fluids.

Major routes include:

1. Perinatal transmission

Transmission from an infected mother to her baby around the time of birth is an important route.

2. Sexual transmission

Unprotected sexual contact with an infected person can transmit HBV.

3. Blood-borne transmission

Examples include:

• Sharing contaminated needles
• Unsafe injections
• Transfusion of contaminated blood or blood products
• Accidental exposure to infected blood
• Unsterile tattooing or piercing equipment

Pathogenesis

HBV enters the bloodstream and reaches the liver. It infects hepatocytes and replicates inside them.

The immune response against infected hepatocytes is a major cause of liver injury.

If the immune response successfully controls the infection, acute hepatitis resolves. If the virus persists, chronic hepatitis may develop.

Chronic infection can cause:

Persistent HBV infection → chronic inflammation → fibrosis → cirrhosis → hepatocellular carcinoma

Diseases caused by HBV

1. Acute hepatitis B

Symptoms may include:

• Fever
• Fatigue
• Nausea
• Vomiting
• Abdominal pain
• Jaundice
• Dark urine

2. Chronic hepatitis B

Some infected individuals develop long-term infection. Chronic hepatitis may remain asymptomatic for many years.

3. Cirrhosis

Long-term inflammation and fibrosis can progressively damage the liver and produce cirrhosis.

4. Hepatocellular carcinoma

Chronic HBV infection increases the risk of primary liver cancer, particularly hepatocellular carcinoma.

5. Fulminant hepatitis

A small proportion of acute infections can result in severe liver failure.

 

5. Hepatitis C Virus (HCV)

General Properties

HCV is an enveloped, positive-sense single-stranded RNA virus belonging to the Flaviviridae family.

It has considerable genetic variability. This variability contributes to immune escape and makes development of a broadly effective vaccine difficult.

Transmission

HCV is primarily transmitted through blood-to-blood exposure.

Important routes include:

• Sharing contaminated needles or syringes
• Unsafe medical procedures
• Transfusion of unscreened blood
• Accidental exposure to infected blood
• Unsterile tattooing or piercing

Sexual and mother-to-child transmission can occur but are generally less efficient than blood-borne transmission.

Pathogenesis

After entering the body, HCV reaches the liver and infects hepatocytes.

Viral replication and the host immune response cause inflammation and liver injury.

HCV is particularly important because acute infection frequently progresses to chronic infection.

Long-term infection can produce:

Chronic HCV infection → chronic inflammation → fibrosis → cirrhosis → hepatocellular carcinoma

Diseases caused by HCV

1. Acute hepatitis C

Many patients have few or no symptoms. When symptoms occur, they may include:

• Fatigue
• Nausea
• Loss of appetite
• Abdominal discomfort
• Jaundice

2. Chronic hepatitis C

Persistent infection may continue for many years without obvious symptoms.

3. Cirrhosis

Long-term inflammation can produce fibrosis and eventually cirrhosis.

4. Hepatocellular carcinoma

Chronic HCV infection increases the risk of liver cancer, particularly after cirrhosis develops.

Extrahepatic manifestations

HCV can also be associated with certain diseases outside the liver, including some immune-mediated disorders.

 

6. Hepatitis D Virus (HDV)

General Properties

HDV is an unusual and defective RNA virus. It requires HBV to complete its life cycle.

HDV cannot produce its own complete envelope. Instead, it uses HBsAg from HBV.

Therefore:

HDV infection requires HBV infection.

Transmission

HDV transmission is similar to HBV transmission.

It can occur through:

• Infected blood
• Contaminated needles
• Sexual contact
• Perinatal transmission, although less common

Types of HDV infection

1. Co-infection

HBV and HDV infect a person at approximately the same time.

HBV + HDV → acute hepatitis

2. Superinfection

HDV infects a person who already has chronic HBV infection.

Superinfection can result in more severe liver disease and has a greater risk of chronic progression.

Pathogenesis

HDV infects hepatocytes in the presence of HBV. The combined infection can cause substantial liver inflammation and injury.

HDV superinfection is particularly associated with rapid progression of chronic liver disease.

Diseases caused by HDV

• Acute hepatitis
• Severe acute hepatitis
• Chronic hepatitis D
• Progressive liver disease
• Cirrhosis
• Increased risk of liver failure

Important point

Prevention of HBV infection through HBV vaccination also prevents HDV infection, because HDV requires HBV.

 

7. Hepatitis E Virus (HEV)

General Properties

HEV is a positive-sense single-stranded RNA virus belonging to the Hepeviridae family.

It is an important cause of acute viral hepatitis worldwide.

Transmission

The major route is the fecal–oral route.

Transmission can occur through:

• Contaminated drinking water
• Contaminated food
• Poor sanitation
• Consumption of contaminated or inadequately cooked animal products in some settings

HEV can also be transmitted from an infected mother to her baby and through blood in some circumstances.

Pathogenesis

After ingestion, HEV reaches the liver and replicates in hepatocytes.

The immune response against infected liver cells contributes to liver inflammation and damage.

Most infections resolve spontaneously, but severe disease can occur in certain groups.

Diseases caused by HEV

1. Acute hepatitis E

Symptoms include:

• Fever
• Fatigue
• Loss of appetite
• Nausea
• Vomiting
• Abdominal pain
• Dark urine
• Jaundice

2. Severe hepatitis

Severe acute liver disease can occur in some patients.

3. Hepatitis E in pregnancy

HEV infection can be particularly serious during pregnancy, especially in some outbreaks and settings.

4. Chronic hepatitis E

Chronic infection is uncommon in healthy individuals but can occur particularly in people with weakened immune systems.

 

8. Hepatitis G Virus (HGV/GBV-C)

General Properties

HGV is also known as GB virus C (GBV-C). It is an enveloped, positive-sense RNA virus related to HCV.

It can persist in the human body, but its exact clinical importance remains uncertain.

Transmission

HGV/GBV-C is mainly transmitted through blood and blood-associated exposure.

Possible routes include:

• Blood transfusion
• Contaminated needles
• Organ transplantation
• Mother-to-child transmission
• Sexual transmission

Pathogenesis

The virus can be detected in blood and lymphoid tissues. Unlike the major hepatitis viruses, its role in causing clinically significant hepatitis has not been clearly established.

Diseases associated with HGV

HGV was initially considered a possible cause of hepatitis. However, current evidence does not establish it as a major cause of clinically important hepatitis.

Therefore, it is more accurate to state:

• HGV/GBV-C infection can occur in humans.
• Persistent infection can occur.
• It may be found in individuals with other viral infections.
• Its role as a direct cause of hepatitis remains uncertain.
• It is not considered a major cause of chronic liver disease in the same way as HBV or HCV.

 

 

9. Comparison of Hepatitis Viruses

Feature	HAV	HBV	HCV	HDV	HEV	HGV
Genome	RNA	DNA	RNA	RNA	RNA	RNA
Envelope	No	Yes	Yes	Yes*	Usually no	Yes
Main route	Fecal–oral	Blood/body fluids	Blood	Blood/body fluids	Fecal–oral	Blood/body fluids
Acute hepatitis	Yes	Yes	Yes	Yes	Yes	Not clearly established
Chronic infection	No	Yes	Yes	Yes	Rare	Can persist
Cirrhosis risk	No chronic disease	Yes	Yes	Yes	Rare	Uncertain
Liver cancer risk	No	Yes	Yes	Indirectly with chronic HBV/HDV	Not a major feature	Uncertain
Vaccine available	Yes	Yes	No	Prevented by HBV vaccination	Limited/availability varies by country	No

*HDV uses HBV surface antigen to form its envelope.

 

10. Major Differences in Transmission

Fecal–oral hepatitis viruses

HAV and HEV

Contaminated:
Food/water → mouth → intestine → liver

These viruses are strongly associated with sanitation and hygiene.

Blood/body-fluid transmitted viruses

HBV, HCV and HDV

Major sources include:
Blood → contaminated equipment/needles or other exposure → bloodstream → liver

HGV/GBV-C is also mainly associated with blood and body-fluid exposure.

 

11. Clinical Features of Viral Hepatitis

Although the different viruses have different characteristics, many forms of acute viral hepatitis can produce similar symptoms.

Common symptoms

1. Fever
2. Fatigue
3. Loss of appetite
4. Nausea
5. Vomiting
6. Abdominal discomfort
7. Dark urine
8. Pale-colored stool
9. Jaundice
10. Enlarged or tender liver in some patients

Some infections, especially HCV and HBV, can remain asymptomatic for a long period.

 

12. Complications of Viral Hepatitis

Serious complications may include:

1. Chronic hepatitis

Persistent viral infection causes continuing inflammation of the liver.

2. Fibrosis

Repeated liver injury causes excess deposition of connective tissue.

3. Cirrhosis

Extensive fibrosis changes the normal structure and function of the liver.

4. Liver failure

Severe liver damage can result in loss of liver function.

5. Hepatocellular carcinoma

Chronic HBV and HCV infection are important risk factors for primary liver cancer.

 

13. Prevention and Control

HAV

• Safe drinking water
• Proper sanitation
• Hand washing
• Safe food preparation
• Vaccination

HBV

• Hepatitis B vaccination
• Screening of donated blood
• Safe injection practices
• Avoiding sharing needles
• Use of sterile medical equipment
• Appropriate precautions during sexual contact
• Prevention of mother-to-child transmission

HCV

• Screening of blood and blood products
• Safe injection practices
• Avoiding sharing contaminated needles
• Sterile medical and tattoo equipment
• Early diagnosis and treatment

There is currently no widely available vaccine for HCV.

HDV

• Prevention of HBV infection
• HBV vaccination
• Safe blood practices
• Avoiding exposure to infected blood and body fluids

Because HDV requires HBV, preventing HBV also prevents HDV.

HEV

• Safe drinking water
• Good sanitation
• Proper hand hygiene
• Safe food preparation
• Adequate cooking of relevant animal-derived foods
• Vaccination where an approved vaccine is available

HGV

There is no established specific vaccine for HGV/GBV-C. Prevention mainly involves reducing exposure to infected blood and following safe medical and blood-handling practices.

 

14. Conclusion

Hepatitis viruses are a diverse group of viruses that can cause inflammation and injury of the liver. HAV and HEV are primarily fecal–oral viruses and usually cause acute disease, whereas HBV and HCV are important causes of chronic hepatitis, cirrhosis, and liver cancer. HDV is unique because it depends on HBV for infection and replication, and HDV infection can make HBV-associated liver disease more severe. HGV/GBV-C can persist in humans, but its role as a significant cause of hepatitis remains uncertain.

Understanding the general properties, transmission routes, pathogenesis, and diseases caused by these viruses is essential for diagnosis, prevention, and control of viral hepatitis. Vaccination is highly effective for preventing HAV and HBV, while sanitation, safe food and water, blood safety, infection-control practices, and early diagnosis are important measures for controlling viral hepatitis.

References

1. Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. Medical Microbiology. Elsevier.
2. Jawetz, Melnick & Adelberg. Medical Microbiology. McGraw-Hill.
3. Brooks, G. F. et al. Jawetz, Melnick & Adelberg’s Medical Microbiology. McGraw-Hill.
4. Ryan, K. J., & Ray, C. G. Sherris Medical Microbiology. McGraw-Hill.
5. World Health Organization (WHO). Hepatitis and viral hepatitis resources.
6. Centers for Disease Control and Prevention (CDC). Viral Hepatitis resources.